BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17389013)

  • 1. Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis.
    Beretta L; Cappiello F; Barili M; Scorza R
    Tissue Antigens; 2007 Apr; 69(4):305-12. PubMed ID: 17389013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the 5' flanking region of the interleukin 10 gene in patients with systemic sclerosis.
    Crilly A; Hamilton J; Clark CJ; Jardine A; Madhok R
    Rheumatology (Oxford); 2003 Nov; 42(11):1295-8. PubMed ID: 12867583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome.
    Hulkkonen J; Pertovaara M; Antonen J; Lahdenpohja N; Pasternack A; Hurme M
    Arthritis Rheum; 2001 Jan; 44(1):176-9. PubMed ID: 11212157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation.
    Zheng HX; Burckart GJ; McCurry K; Webber S; Ristich J; Iacono A; Dauber J; McDade K; Grgurich W; Zaldonis D; Pillage G; Griffith BP; Zeevi A
    J Heart Lung Transplant; 2004 May; 23(5):541-6. PubMed ID: 15135368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients.
    Beretta L; Cappiello F; Moore JH; Barili M; Greene CS; Scorza R
    Arthritis Rheum; 2008 Jul; 59(7):974-83. PubMed ID: 18576303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology.
    Beretta L; Bertolotti F; Cappiello F; Barili M; Masciocchi M; Toussoun K; Caronni M; Scorza R
    Hum Immunol; 2007 Jul; 68(7):603-9. PubMed ID: 17584583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10 gene promoter and NFKB1 promoter insertion/deletion polymorphisms in systemic sclerosis.
    Salim PH; Jobim M; Bredemeier M; Chies JA; Brenol JC; Jobim LF; Xavier RM
    Scand J Immunol; 2013 Feb; 77(2):162-8. PubMed ID: 23237063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus.
    van der Linden MW; Westendorp RG; Sturk A; Bergman W; Huizinga TW
    J Investig Med; 2000 Sep; 48(5):327-34. PubMed ID: 10979237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. -238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis.
    Tolusso B; Fabris M; Caporali R; Cuomo G; Isola M; Soldano F; Montecucco C; Valentini G; Ferraccioli G
    Immunol Lett; 2005 Jan; 96(1):103-8. PubMed ID: 15585313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorheologic profile in systemic sclerosis: role of NOS3 -786T > C and 894G >T polymorphisms in modulating both the hemorheologic parameters and the susceptibility to the disease.
    Fatini C; Mannini L; Sticchi E; Rogai V; Guiducci S; Conforti ML; Cinelli M; Pignone AM; Bolli P; Abbate R; Cerinic MM
    Arthritis Rheum; 2006 Jul; 54(7):2263-70. PubMed ID: 16802365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.
    Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
    J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of the interleukin-1alpha (IL-1alpha-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals.
    Kilpinen S; Huhtala H; Hurme M
    Eur Cytokine Netw; 2002; 13(1):66-71. PubMed ID: 11956022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.
    Karabon L; Wysoczanska B; Bogunia-Kubik K; Suchnicki K; Lange A
    Hum Immunol; 2005 Jun; 66(6):700-10. PubMed ID: 15993715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis.
    Hikami K; Ehara Y; Hasegawa M; Fujimoto M; Matsushita M; Oka T; Takehara K; Sato S; Tokunaga K; Tsuchiya N
    Biochem Biophys Res Commun; 2008 Aug; 373(3):403-7. PubMed ID: 18588853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interleukin-10 promoter haplotype ATA is a putative risk factor for aggressive periodontitis.
    Reichert S; Machulla HK; Klapproth J; Zimmermann U; Reichert Y; Gläser CH; Schaller HG; Stein J; Schulz S
    J Periodontal Res; 2008 Feb; 43(1):40-7. PubMed ID: 18230105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allograft inflammatory factor-1 and tumor necrosis factor single nucleotide polymorphisms in systemic sclerosis.
    Otieno FG; Lopez AM; Jimenez SA; Gentiletti J; Artlett CM
    Tissue Antigens; 2007 Jun; 69(6):583-91. PubMed ID: 17498268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis.
    Tsuchiya N; Kuroki K; Fujimoto M; Murakami Y; Tedder TF; Tokunaga K; Takehara K; Sato S
    Arthritis Rheum; 2004 Dec; 50(12):4002-7. PubMed ID: 15593213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism.
    Helminen ME; Kilpinen S; Virta M; Hurme M
    J Infect Dis; 2001 Sep; 184(6):777-80. PubMed ID: 11517440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.